Cancer
-
ReviewOpen for discovery
The Francis Crick Institute’s first exhibition showcases its scientists’ research
-
BusinessCelgene pays $280m to settle off-label marketing lawsuit
Whistleblower case relating to cancer prescriptions
-
BusinessLilly wins chemotherapy patent appeal
Firm also settles with generic manufacturers of erectile dysfunction drug Cialis
-
BusinessCelgene and BeiGene agree cancer partnership
Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
-
PodcastCaesium chloride
A compound found in mineral water that is also used in medical treatments and solar cells
-
NewsEuropean chemicals body links titanium dioxide to cancer
Chemical found in everything from paint to toothpaste added to list of suspected carcinogens over inhalation risk
-
BusinessFirst biomarker-driven approval exemplifies cancer immunotherapy progress
Landmark decision is latest step in field’s impressive – but not wholly untroubled – advance
-
BusinessSeattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
BusinessJ&J fights talc cancer claims
Firm has lost several court cases linking talc to ovarian cancer, but vows to appeal
-
NewsEx-Harvard postdoc sues university for drug royalties
Former Harvard chemist says he lost out on millions after the technology he worked on was licensed to Merck & Co
